Project Grant HT94252510494
Award Date
6/1/25
Completion Date
5/31/27
Dollars Obligated
$159K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Nashville, TN 37203, USA
Similar Awards
This federal Project Grant award in the amount of $2,399,874.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The research at Vanderbilt University Medical Center, the grant recipient, aims to decode the inflammatory response and unravel the molecular basis of post-injury syndrome...
The Defense Health Agency awarded Vanderbilt University a $317,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420). The grant will support Vanderbilt's project "Systematic Pipeline for ADAR-Mediated Transcript Therapeutics in Rett Syndrome" from July 1, 2023 to June 30, 2024. The project aims to develop transcript-targeting therapies for Rett Syndrome by investigating the role of RNA editing enzymes. This work aligns with the Military Medical...
The Defense Health Agency awarded Vanderbilt University Medical Center a $1,567,553 Project Grant under the Military Medical Research and Development federal grant program (CFDA 12.420). The two-year grant will fund research to optimize therapeutic control of epilepsy in tuberous sclerosis complex using a novel biosensor. Per the award description, following preclinical and pilot human studies, Vanderbilt predicts that larger clinical trials will demonstrate improved control of epilepsy using...
The Defense Health Agency awarded a $682,049 Project Grant to The Washington University under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research to transform military and public...
This $1,211,469 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports a therapeutic intervention research project to reverse gastric precancer conducted by Vanderbilt University Medical Center (VUMC). The award, with a performance period from June 1, 2024 to May 31, 2028, will enable VUMC to leverage its clinical expertise and research capabilities to advance medical knowledge and improve patient care. As a leading...
This $819,195 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by Drexel University on the PEDF PLXDC1 ADNP signaling pathways related to neuromorphogenesis and neural circuit development. The award, which runs from September 15, 2023 to September 14, 2026, will fund basic, translational, and clinical research aimed at advancing scientific understanding and developing new treatments in areas such as...
This $1,525,000 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports foundational studies at the University of Florida to understand the phenotypic, region-specific, and cell-specific dysregulation in the central nervous system of individuals with myotonic dystrophy. The 4-year award, effective May 15, 2024, will enable the university to conduct innovative research to advance the understanding of this neurological...
This federal Project Grant award, valued at $959,996.00 and issued by the Defense Health Agency, is supporting research conducted by Northwestern University under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant is focused on "Targeting SPOP and BRD4 to Blunt the Toxicity of C9orf72-Derived Dipeptide Repeat Proteins," with the goal of advancing biomedical research to transform healthcare for military service members and the general public....
This federal Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) provides $1,659,679.00 in funding to the University of California, Los Angeles (UCLA) to conduct research targeting heterogeneity in NF2-mutant tumors. The award period runs from September 15, 2024 through September 14, 2027. The key products and services to be delivered under this grant include innovative scientific research, laboratory studies, and...
The Defense Health Agency awarded a $697,766 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to the Murdoch Children's Research Institute in Australia. The grant, awarded on July 15, 2024, will fund a 3-year research project titled "BRAIN CHARTS IN CHILDREN AND ADOLESCENTS WITH NEUROFIBROMATOSIS TYPE 1". The project aims to conduct biomedical research to better understand and characterize brain development in children and adolescents with...